Planned Parenthood Los Angeles - Dorothy Hecht CTR
Planned Parenthood Los Angeles - Dorothy Hecht CTR was paid $6.07M by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is J3490, Unclassified drugs — 15% of everything it billed.
LOS ANGELES, CA 90003
Next to other Community Health Clinic/Center providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,243 | $1.04M | |
| 2019 | 19,768 | $746K | |
| 2020 | 28,441 | $928K | |
| 2021 | 27,271 | $1.04M | |
| 2022 | 19,854 | $762K | |
| 2023 | 22,071 | $835K | |
| 2024incomplete | 16,848 | $708K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J3490 | Unclassified drugs | 15% | 23,822 | 20,554 | $892K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 12% | 773 | 770 | $749K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 11% | 13,757 | 13,151 | $637K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 5,298 | 5,020 | $635K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.2% | 5,025 | 4,932 | $438K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.8% | 1,137 | 1,108 | $355K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.3% | 1,849 | 1,790 | $324K |
| S4993 | Contraceptive pills for birth control | 5.3% | 4,373 | 4,346 | $322K |
| 87806 | 4.5% | 11,561 | 9,138 | $275K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.8% | 1,284 | 1,279 | $231K |
| 11981 | 2.9% | 701 | 701 | $177K | |
| A4267 | Contraceptive supply, condom, male, each | 2.4% | 21,879 | 21,311 | $147K |
34 more codes
| 99201 | 1.8% | 1,025 | $106K | |
| 58300 | 1.5% | 932 | $94K | |
| 81025 | 1.5% | 18,803 | $93K | |
| 99401 | 1.3% | 4,003 | $76K | |
| 11976 | 1.1% | 1,027 | $67K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 1.1% | 156 | $67K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 140 | $53K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 3,034 | $39K |
| S5000 | Prescription drug, generic | <1% | 5,186 | $35K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | <1% | 61 | $28K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,273 | $27K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 39 | $26K |
| 99000 | <1% | 7,567 | $25K | |
| 86703 | <1% | 2,390 | $23K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,287 | $20K |
| 83986 | <1% | 7,230 | $20K | |
| 59840 | <1% | 92 | $18K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 3,859 | $14K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 2,146 | $10K |
| 58301 | <1% | 234 | $7K | |
| 86592 | <1% | 2,465 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 413 | $6K |
| S0190 | Mifepristone, oral, 200 mg | <1% | 76 | $4K |
| 82120 | <1% | 988 | $3K | |
| 99402 | <1% | 102 | $3K | |
| 81002 | <1% | 1,668 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 538 | $3K |
| 87210 | <1% | 876 | $3K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 25 | $2K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 25 | $2K |
| Z7610 | <1% | 57 | $370.03 | |
| 85018 | <1% | 188 | $343.05 | |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 104 | $219.25 |
| 86901 | <1% | 28 | $65.65 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.